Institutional Ownership Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). We have compiled data on the 209 institutions that hold shares in the stock, with a total of 66.9 Million shares, which have been reported (via 13F filing form) to have a value of $3.03 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Hudson Bay Capital Management LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
175,000
shares
|
$7.91 Million
0.02% of portfolio
|
Q4 2024
Added 12.9%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
171,518
shares
|
$7.76 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.94%
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
169,654
shares
|
$7.67 Million
0.0% of portfolio
|
Q4 2024
Added 37.42%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
165,000
shares
|
$7.46 Million
2.04% of portfolio
|
Q4 2024
New holding
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
155,044
shares
|
$7.01 Million
0.01% of portfolio
|
Q3 2024
Reduced 34.72%
|
|
Springhill Fund Asset Management (Hk) CO LTD
Hong Kong, K3 |
Feb 13, 2025 Q4 2024 |
151,200
shares
|
$6.84 Million
6.83% of portfolio
|
Q4 2024
New holding
|
|
Pdt Partners, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
137,030
shares
|
$6.2 Million
0.38% of portfolio
|
Q4 2024
Reduced 1.63%
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
134,705
shares
|
$6.09 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
132,837
shares
|
$6.01 Million
0.0% of portfolio
|
Q4 2024
Added 4.05%
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
127,320
shares
|
$5.76 Million
0.01% of portfolio
|
Q4 2024
Added 43.35%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
124,592
shares
|
$5.63 Million
0.0% of portfolio
|
Q4 2024
Added 29.05%
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
112,442
shares
|
$5.08 Million
0.0% of portfolio
|
Q4 2024
Added 55.07%
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
105,686
shares
|
$4.78 Million
0.0% of portfolio
|
Q4 2024
Added 1.26%
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
98,463
shares
|
$4.45 Million
0.0% of portfolio
|
Q4 2024
Added 27.25%
|
|
Swiss National Bank
Zurich, V8 |
Feb 10, 2025 Q4 2024 |
95,600
shares
|
$4.32 Million
0.0% of portfolio
|
Q4 2024
Added 1.16%
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
87,917
shares
|
$3.98 Million
0.0% of portfolio
|
Q4 2024
Added 69.46%
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
82,000
shares
|
$3.71 Million
0.26% of portfolio
|
Q4 2024
New holding
|
|
Rafferty Asset Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
72,604
shares
|
$3.28 Million
0.01% of portfolio
|
Q4 2024
Reduced 19.69%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
71,451
shares
|
$3.23 Million
0.0% of portfolio
|
Q4 2024
Added 18.27%
|
|
Exome Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
68,608
shares
|
$3.1 Million
1.43% of portfolio
|
Q4 2024
Reduced 11.01%
|
|
Cinctive Capital Management LP
New York, NY |
Feb 12, 2025 Q4 2024 |
67,964
shares
|
$3.07 Million
0.1% of portfolio
|
Q4 2024
Added 4.07%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
66,264
shares
|
$3 Million
0.0% of portfolio
|
Q4 2024
Reduced 58.47%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
66,000
shares
|
$2.98 Million
0.05% of portfolio
|
Q4 2024
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
61,867
shares
|
$2.8 Million
0.0% of portfolio
|
Q4 2024
Added 13.98%
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
61,497
shares
|
$2.78 Million
0.11% of portfolio
|
Q2 2023
New holding
|